1. Verity DH, Wallace GR, Vaughan RW, et al. Behcet’s disease:fromHippocrates to the third millennium. Br J Ophthalmol.2003;87:1175-83.
2. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al. Uveitis inBehçet disease:An analysis of 880 patients. Am J Ophthalmol.2004;138:373-380.
3. Kitaichi N, Miyazaki A, Stanford MR, et al. Ocular featuresof Behcet’s disease:An international collaborative study. Br JOphthalmol. 2007;91:1579-1582.
4. Ozdal PC, Ortac S, Taskintuna I, Firat E. Posterior segmentinvolvement in ocular Behçet's disease. Eur J Ophthalmol.2002;12:424-431.
5. Charteris DG, Barton K, McCartney AC, Lightman SL.CD4þ lymphocyte involvement in ocular Behcet’s disease.Autoimmunity. 1992;12:201-206. 4.
6. George RK, Chan CC, Whitcup SM, Nussenblatt RB. Ocularimmunopathology of Behcet’s disease. Surv Ophthalmol.1997;42:157-162.
7. Atmaca LS, Sonmez PA. Fluorescein and indocyanine greenangiography findings in Behçet’s disease. Br J Ophthalmol.2003;87:1466-1468.
8. Bozzoni-Pantaleoni F, Gharbiya M, Pirraglia MP, et al.Indocyanine green angiographic findings in Behcet disease.Retina. 2001;21:230-236.
9. Onal S, Tugal-Tutkun I, Neri P, Herbort CP. Optical coherencetomography imaging in uveitis. Int Ophthalmol. 2013;34:401-435
10. International Study Group for Behçet’s Disease. Criteria fordiagnosis of Behcet’s disease. Lancet. 1990;335:1078-1080.
11. Gupta V, Gupta P, Singh R, Dogra MR, Gupta A. Spectral-domain Cirrus high-definition optical coherence tomography isbetter than time-domain Stratus optical coherence tomographyfor evaluation of macular pathologic features in uveitis.Am J Ophthalmol. 2008;145(6):1018-1022. doi:10.1016/j.ajo.2008.01.021
12. Paunescu LA, Schuman JS, Price LL, et al. Reproducibility ofnerve fiber thickness, macular thickness, and optic nerve headmeasurements using StratusOCT. Invest Ophthalmol Vis Sci.2004;45(6):1716-1724.
13. Spaide RF. Enhanced depth imaging optical coherencetomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol. 2009;147(4):644-652.
14. Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF.Enhanced depth imaging optical coherence tomographyof the choroid in highly myopic eyes. Am J Ophthalmol.2009;148(3):445-450.
15. Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T. Subfovealchoroidal thickness in fellow eyes of patients with central serouschorioretinopathy. Retina. 2011;31(8):1603-1608. doi:10.1097/IAE.0b013e31820f4b39
16. Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A. Clinicalfeatures of chinese patients with Behçet's disease. Ophthalmology.2008;115(2):312-318.e4. doi:10.1016/j.ophtha.2007.04.056
17. Tugal-Tutkun I. Behçet's Uveitis. Middle East Afr J Ophthalmol.2009;16(4):219-224. doi:10.4103/0974-9233.58425
18. Grover S, Murthy RK, Brar VS, Chalam KV. Normative datafor macular thickness by high-definition spectral-domainoptical coherence tomography (spectralis). Am J Ophthalmol.2009;148(2):266-271.
19. Takeuchi M, Iwasaki T, Kezuka T, et al. Functional andmorphological changes in the eyes of Behçet's patients withuveitis. Acta Ophthalmol. 2010;88(2):257-262.
20. Tekeli O, Ozdemir O. Heidelberg retina tomograph in ocularBehçet's disease. Eye (Lond). 2004;18(2):143-146.
21. Berker N, Elgin U, Ozdal P, Batman A, Soykan E, Ozkan SS.Topographic optic disc analysis by Heidelberg retinal tomographyin ocular Behcet's disease. Br J Ophthalmol. 2007;91(9):1199-1201.
22. Ataş M, Yuvacı I, Demircan S, et al. Evaluation of the macular,peripapillary nerve fiber layer and choroid thickness changesin Behçet's disease with spectral-domain OCT. J Ophthalmol.2014;2014:865394. doi:10.1155/2014/865394
23. Kim M, Kim H, Kwon HJ, et al. Choroidal thickness in Behcet'suveitis:an enhanced depth imaging optical coherence tomographyand its association with angiographic changes. Invest OphthalmolVis Sci. 2013;54(9):6033-6039.
24. Coskun E, Okumus S, Pehlivan Y, et al. Enhanced depth imagingoptical coherence tomography findings in Behçet disease. OcularImmunol Inflammation. 2013;21(6):440-445
25. Ishikawa S, Taguchi M, MuraokaT, et al. Changes in subfovealchoroidal thickness associated with uveitis activity in patientswith Behçet's disease. Br J Ophtalmol. 2014;1136:305-33
26. Gedik S, Akova Y, Yilmaz G, et al. Indocyanine green and fundusfluorescein angiographic findings in patients with active ocularBehçet's disease. Ocul Immunol Inflamm. 2005;13:51-58.